Widely given to patients with type 2 diabetes, metformin has been linked to reducing the risk for many types of cancers. The medication, however, may not be effective against one certain cancer.

While several medications are already on the market to treat diabetes, not all patients have the desired control over their blood sugar levels. Alogliptin may offer a fresh option.